Company · Healthtech & Bio

Agrenvec

agrenvec.es ↗ ·Tres Cantos ·Series A

Agrenvec is a Madrid-based (Tres Cantos) biotech company specializing in molecular farming, producing recombinant human proteins, growth factors, cytokines, and antibodies using a 100% animal-free, non-transgenic plant system (Nicotiana benthamiana). Founded in 2001-2002, it serves the life sciences/R&D, dermo-cosmetic, and cultivated meat industries, and has raised a Series A round of $2.6M from Spanish VC investors.

Founded

2001

Founders

News

Rounds

Investors

SectorsBiotechnology, Molecular Farming, Cosmetics, Cultivated Meat, Life Sciences Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Profile updated 21 Jul 2026

Founders

Isabel Bronchalo

Founder & CEO

Jorge-Luis Sánchez-Ponz

Co-Founder (exited 2017)

Global models 5

PhaseBio Pharmaceuticals

United States

Biopharmaceutical company that used non-animal recombinant protein production platforms, similar to Agrenvec's animal-free biomanufacturing approach.

$300MComparable

Ventria Bioscience

United States · ventria.com ↗

Uses plant-based (rice) molecular farming to produce recombinant human proteins for life sciences and nutrition, directly comparable to Agrenvec's plant-based protein platform.

$100M+Comparable

Medicago

Canada

Pioneered plant-based (Nicotiana benthamiana) molecular farming for vaccines and proteins, the closest large-scale global comparable to Agrenvec's exact plant-biofactory technology.

$500M+Comparable

iBio

United States · ibioinc.com ↗

Plant-based biomanufacturing company producing recombinant proteins and antibodies using Nicotiana benthamiana, essentially the same platform and target markets as Agrenvec.

$150M+Comparable

Geltor

United States · geltor.com ↗

Produces animal-free recombinant proteins (collagens/elastins) for cosmetics and biotech applications via precision fermentation, matching Agrenvec's animal-free protein-for-cosmetics business model.

$150M+Comparable

Investors 3

AXIS Participaciones Empresariales

Najeti Capital

Investor Spain

Funding rounds

No announced rounds on record.

News & media 2

Published	Article
2026-04-20	Tres Cantos se posiciona como referente en tecnología biológica ↗ 360y5.es
2023-08-21	Carne cultivada en laboratorio para mejorar la sostenibilidad de la industria cárnica ↗ Haz Revista